Maharashtra, India

Gupte Rajan

This inventor holds 1 USPTO granted patent. Top assignee: Reliance Life Sciences Pvt. Ltd.. Active years: 2014.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gupte Rajan: Innovator in Tetrazine Derivatives

Introduction

Gupte Rajan is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals through his innovative work on tetrazine derivatives. His research and inventions have the potential to impact various applications in medicine.

Latest Patents

Gupte Rajan holds a patent for a process for the preparation of tetrazine derivatives. This invention provides a detailed methodology for synthesizing a tetrazine derivative of a specific formula, which includes various alkyl and phenyl groups. The process involves several steps, including the absorption of a compound into a solvent, the addition of another compound to obtain the desired tetrazine derivative, and the optional salification of the compound with a pharmaceutically acceptable acid or base. He has 1 patent to his name.

Career Highlights

Gupte Rajan is currently employed at Reliance Life Sciences Pvt. Ltd., where he continues to explore innovative solutions in the pharmaceutical industry. His work is characterized by a commitment to advancing scientific knowledge and improving healthcare outcomes.

Collaborations

Gupte Rajan collaborates with talented colleagues, including Chaturvedi Rohit and Baviskar Pravin. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Gupte Rajan's contributions to the field of pharmaceuticals, particularly through his patent on tetrazine derivatives, highlight his role as an influential inventor. His ongoing work at Reliance Life Sciences Pvt. Ltd. promises to lead to further advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…